Editor's Note COVID infections are rising nationally, with cases increasing in 39 states and none showing a decline, NBC news reported June 24. The Centers for Disease Control and Prevention (CDC) tracks Covid transmission through emergency department visits, which, along with deaths and hospitalizations, have recently increased, NBC reports. California…
Editor's Note Many people have reportedly been experiencing cold-like symptoms this winter, which have often been attributed to “some bug”; however, there’s a strong chance these symptoms were due to a new surge of COVID-19, Wired January 10 reports. There’s a new, large global surge in daily COVID-19 infections currently…
Editor's Note A new study suggests that someone's initial exposure to a specific COVID-19 variant shows some influence to their immune response to subsequent variants of SARS-CoV-2, the virus responsible for COVID-19, the University of Cambridge October 6 reports. The research, published by Science on October 6 and titled "Mapping…
Editor's Note This new study from the Cleveland Clinic found that use of COVID-19 antiviral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduces risk of hospitalization and death in high-risk patients with mild disease, even against Omicron subvariants. The findings were published in JAMA Network on September 21. The study included…
Editor's Note With COVID-19 rates rising again, and winter cold and flu season around the corner, it is time for healthcare personnel to get a COVID-19 booster shot to help protect against illness–and recommend patients to do the same. In a September 2023 TIME Magazine article, doctors weigh in on…
Editor's Note The COVID-19 Omicron subvariant EG.5 is now the dominant variant in the US, replacing Arcturus XBB.1.16, according to the August 4 US News & World Report. EG.5 accounts for more than 17% of new COVID-19 cases in the US in the past 2 weeks, and it is increasing…